Subpopulations of human polymorphonuclear leukocytes (PMN) have been reported based on variations in rosetting to IgG coated erythrocytes, chemotaxis, binding of FMLP and membrane potential charge upon stimulation. No size differences have been noted among these subpopulations. Counterflow centrifugal elutriation (CCE) separates cells based on differences in size and density. Phase I of the proposal will evaluate volume dependent subpopulations of blood PMN isolated by CCE. Analysis of the early activation events of receptor ligand binding, membrane potential change, and alteration in membrane bound and cytosolic calcium upon stimulation will be performed. Superoxide has already been shown to be greater on a per cell basis in larger subgroups. Evaluation will be done to assess PMN subpopulation lag time and rate of the oxidative burst after stimulation. To determine if specific granule contents have a role in PMN subpopulations, Vit B12 binding protein will be analyzed. This analysis will assess the hypothesis that subpopulations of PMN exist in varying states of """"""""readiness for activation"""""""". Phase II will assess the contribution of storage pool PMN to PMN subpopulations. PMN from bone marrow samples will be compared to peripheral blood PMN. PMN will also be isolated before and after a subcutaneous injection of epinephrine to assess the marginating pool of PMN. To evaluate the role of the spleen in storage of PMN and in volume dependent PMN subpopulations patients undergoing elective splenectomy will have PMN isolated before and after this procedure. These PMN will be compared to peripheral blood PMN by the methods utilized in Phase I. Analysis of shifts in subpopulations of the storage pool PMN will be performed utilizing CCE. Phase III will evaluate volume dependent PMN subpopulations of patients with altered host defenses. Wiskott-Aldrich syndrome, chronic granulomatous disease, burn patients, a patient with PMN lactoferrin deficiency, and sickle cell disease will be assessed. We believe that this information will aid in the understanding of PMN activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Unknown (R23)
Project #
5R23AI022048-03
Application #
3445646
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-09-30
Project End
1987-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Berkow, R L; Dodson, M R (1988) Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leukoc Biol 44:345-52
Curnutte, J T; Berkow, R L; Roberts, R L et al. (1988) Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. J Clin Invest 81:606-10
Berkow, R L; Wang, D; Larrick, J W et al. (1987) Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 139:3783-91
Berkow, R L; Dodson, R W (1987) Volume dependent polymorphonuclear leukocytes fractions isolated by counterflow centrifugal elutriation: PMN volume does not correlate with PMN age. J Leukoc Biol 41:518-26
Kraft, A S; Berkow, R L (1987) Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leukocytes. Blood 70:356-62
Berkow, R L; Dodson, R W; Kraft, A S (1987) Dissociation of human neutrophil activation events by prolonged treatment with amiloride. J Lab Clin Med 110:97-105
Berkow, R L; Dodson, R W (1987) Functional analysis of the marginating pool of human polymorphonuclear leukocytes. Am J Hematol 24:47-54
Kraft, A S; Appling, C; Berkow, R L (1987) Specific binding of phorbol esters to nuclei of human promyelocytic leukemia cells. Biochem Biophys Res Commun 144:393-401
Berkow, R L; Dodson, R W (1986) Purification and functional evaluation of mature neutrophils from human bone marrow. Blood 68:853-60
Berkow, R L; Kraft, A S (1985) Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem Biophys Res Commun 131:1109-16